Physician profile
Robert Joseph Applegate
NPI 1740265032
$1,793.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,072 · 2020: $81.50 · 2021: $156 · 2022: $484.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $841.43 | 2019-2022 | |
| Edwards Lifesciences Corporation | $320.28 | 2019-2022 | |
| Abbott Laboratories | $211.19 | 2019-2021 | |
| Corindus INC. | $146.32 | 2019 | |
| Abiomed | $113.14 | 2021-2022 | |
| Medtronic Vascular, INC. | $97.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2021 | |
| Shockwave Medical, INC | $25.35 | 2022 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Applegate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.